| Year |
Citation |
Score |
| 2020 |
Desikan R, Raja R, Dixit NM. Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection. Plos Computational Biology. 16: e1008064. PMID 32817614 DOI: 10.1371/Journal.Pcbi.1008064 |
0.313 |
|
| 2019 |
Raja R, Pareek A, Newar K, Dixit NM. Mutational pathway maps and founder effects define the within-host spectrum of hepatitis C virus mutants resistant to drugs. Plos Pathogens. 15: e1007701. PMID 30934020 DOI: 10.1371/Journal.Ppat.1007701 |
0.31 |
|
| 2018 |
Raja R, Baral S, Dixit NM. Interferon at the cellular, individual, and population level in hepatitis C virus infection: Its role in the interferon-free treatment era. Immunological Reviews. 285: 55-71. PMID 30129199 DOI: 10.1111/Imr.12689 |
0.318 |
|
| 2018 |
Venugopal V, Padmanabhan P, Raja R, Dixit NM. Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection. Plos Computational Biology. 14: e1006335. PMID 30001324 DOI: 10.1371/Journal.Pcbi.1006335 |
0.321 |
|
| 2018 |
Baral S, Roy R, Dixit NM. Modelling how reversal of immune exhaustion elicits cure of chronic hepatitis C after the end of treatment with direct-acting antiviral agents. Immunology and Cell Biology. PMID 29744934 DOI: 10.1111/Imcb.12161 |
0.333 |
|
| 2018 |
Gupta V, Dixit NM. Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents. Plos Computational Biology. 14: e1006004. PMID 29451894 DOI: 10.1371/Journal.Pcbi.1006004 |
0.344 |
|
| 2016 |
Shet A, Nagaraja P, Dixit NM. Viral decay dynamics and mathematical modeling of treatment response: evidence of lower in vivo fitness of HIV-1 subtype C. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27273158 DOI: 10.1097/Qai.0000000000001101 |
0.312 |
|
| 2015 |
Gupta V, Dixit NM. Scaling law characterizing the dynamics of the transition of HIV-1 to error catastrophe. Physical Biology. 12: 054001. PMID 26331636 DOI: 10.1088/1478-3975/12/5/054001 |
0.322 |
|
| 2014 |
Thangavelu PU, Gupta V, Dixit NM. Estimating the fraction of progeny virions that must incorporate APOBEC3G for suppression of productive HIV-1 infection. Virology. 449: 224-8. PMID 24418556 DOI: 10.1016/J.Virol.2013.11.026 |
0.317 |
|
| 2012 |
Tripathi K, Balagam R, Vishnoi NK, Dixit NM. Stochastic simulations suggest that HIV-1 survives close to its error threshold. Plos Computational Biology. 8: e1002684. PMID 23028282 DOI: 10.1371/Journal.Pcbi.1002684 |
0.319 |
|
| 2011 |
Padmanabhan P, Dixit NM. Mathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entry. Plos Computational Biology. 7: e1002307. PMID 22174670 DOI: 10.1371/Journal.Pcbi.1002307 |
0.302 |
|
| 2011 |
Mulampaka SN, Dixit NM. Estimating the threshold surface density of Gp120-CCR5 complexes necessary for HIV-1 envelope-mediated cell-cell fusion. Plos One. 6: e19941. PMID 21647388 DOI: 10.1371/Journal.Pone.0019941 |
0.333 |
|
| 2011 |
Krishnan SM, Dixit NM. Ribavirin-induced anemia in hepatitis C virus patients undergoing combination therapy. Plos Computational Biology. 7: e1001072. PMID 21304937 DOI: 10.1371/Journal.Pcbi.1001072 |
0.322 |
|
| 2011 |
Balagam R, Singh V, Sagi AR, Dixit NM. Taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of HIV-1. Plos One. 6: e14531. PMID 21249189 DOI: 10.1371/Journal.Pone.0014531 |
0.328 |
|
| 2010 |
Gadhamsetty S, Dixit NM. Estimating frequencies of minority nevirapine-resistant strains in chronically HIV-1-infected individuals naive to nevirapine by using stochastic simulations and a mathematical model. Journal of Virology. 84: 10230-40. PMID 20668070 DOI: 10.1128/Jvi.01010-10 |
0.316 |
|
| 2008 |
Vijay NN, Vasantika, Ajmani R, Perelson AS, Dixit NM. Recombination increases human immunodeficiency virus fitness, but not necessarily diversity. The Journal of General Virology. 89: 1467-77. PMID 18474563 DOI: 10.1099/Vir.0.83668-0 |
0.32 |
|
| 2008 |
Mohanty U, Dixit NM. Mechanism-based model of the pharmacokinetics of enfuvirtide, an HIV fusion inhibitor. Journal of Theoretical Biology. 251: 541-51. PMID 18258267 DOI: 10.1016/J.Jtbi.2007.12.017 |
0.324 |
|
| 2007 |
Suryavanshi GW, Dixit NM. Emergence of recombinant forms of HIV: dynamics and scaling. Plos Computational Biology. 3: 2003-18. PMID 17967052 DOI: 10.1371/Journal.Pcbi.0030205 |
0.367 |
|
| 2006 |
Boyd MA, Dixit NM, Siangphoe U, Buss NE, Salgo MP, Lange JM, Phanuphak P, Cooper DA, Perelson AS, Ruxrungtham K. Viral decay dynamics in HIV-infected patients receiving ritonavir-boosted saquinavir and efavirenz with or without enfuvirtide: a randomized, controlled trial (HIV-NAT 012). The Journal of Infectious Diseases. 194: 1319-22. PMID 17041859 DOI: 10.1086/508291 |
0.304 |
|
| 2005 |
Dixit NM, Perelson AS. HIV dynamics with multiple infections of target cells. Proceedings of the National Academy of Sciences of the United States of America. 102: 8198-203. PMID 15928092 DOI: 10.1073/Pnas.0407498102 |
0.334 |
|
| 2004 |
Dixit NM, Perelson AS. Multiplicity of human immunodeficiency virus infections in lymphoid tissue. Journal of Virology. 78: 8942-5. PMID 15280505 DOI: 10.1128/Jvi.78.16.8942-8945.2004 |
0.322 |
|
| 2004 |
Dixit NM, Perelson AS. Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay. Journal of Theoretical Biology. 226: 95-109. PMID 14637059 DOI: 10.1016/J.Jtbi.2003.09.002 |
0.308 |
|
| 2003 |
Dixit NM, Zukoski CF. Competition between crystallization and gelation: a local description. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 67: 061501. PMID 16241227 DOI: 10.1103/Physreve.67.061501 |
0.571 |
|
| 2003 |
Powers KA, Dixit NM, Ribeiro RM, Golia P, Talal AH, Perelson AS. Modeling viral and drug kinetics: hepatitis C virus treatment with pegylated interferon alfa-2b. Seminars in Liver Disease. 23: 13-8. PMID 12934163 DOI: 10.1055/S-2003-41630 |
0.315 |
|
| 2003 |
Kulkarni AM, Dixit NM, Zukoski CF. Ergodic and non-ergodic phase transitions in globular protein suspensions. Faraday Discussions. 123: 37-50; discussion 75. PMID 12638853 DOI: 10.1039/B204453F |
0.673 |
|
| 2003 |
Dixit NM, Zukoski CF. Pseudo-steady rates of crystal nucleation in suspensions of charged colloidal particles Journal of Physics Condensed Matter. 15: 1531-1552. DOI: 10.1088/0953-8984/15/10/303 |
0.568 |
|
| 2003 |
Zukoski CF, Kulkarni AM, Dixit NM. Response to: On methods of determination of homogeneous nucleation rates of protein crystals Colloids and Surfaces a: Physicochemical and Engineering Aspects. 215: 137-140. DOI: 10.1016/S0927-7757(02)00424-7 |
0.675 |
|
| 2002 |
Dixit NM, Zukoski CF. Nucleation rates and induction times during colloidal crystallization: links between models and experiments. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 66: 051602. PMID 12513493 DOI: 10.1103/Physreve.66.051602 |
0.603 |
|
| 2002 |
Dixit NM, Zukoski CF. Crystal nucleation rates for particles experiencing anisotropic interactions Journal of Chemical Physics. 117: 8540-8550. DOI: 10.1063/1.1514221 |
0.567 |
|
| 2001 |
Dixit NM, Zukoski CF. Kinetics of crystallization in hard-sphere colloidal suspensions. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 64: 041604. PMID 11690037 DOI: 10.1103/Physreve.64.041604 |
0.606 |
|
| 2001 |
Dixit NM, Kulkarni AM, Zukoski CF. Comparison of experimental estimates and model predictions of protein crystal nucleation rates Colloids and Surfaces a: Physicochemical and Engineering Aspects. 190: 47-60. DOI: 10.1016/S0927-7757(01)00664-1 |
0.698 |
|
| 2000 |
Dixit NM, Zukoski CF. Crystal Nucleation Rates for Particles Experiencing Short-Range Attractions: Applications to Proteins. Journal of Colloid and Interface Science. 228: 359-371. PMID 10926476 DOI: 10.1006/jcis.2000.6944 |
0.527 |
|
| Show low-probability matches. |